Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 23256X100 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (2) | ||||
|
Orbimed Advisors LLC
13G
|
4.9% |
2/17/2026
Event 12/31/2025
|
||
| Orbimed Advisors LLC | 2.8% | |||
| Orbimed Capital LLC | 4.9% | |||
|
RA Capital Management, L.P.
13G/A
|
0% |
2/14/2025
Event 12/31/2024
|
||
| RA Capital Management, L.P. | 0% | |||
| Peter Kolchinsky | 0% | |||
| Rajeev Shah | 0% | |||
| RA Capital Healthcare Fund, L.P. | 0% | |||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2024 Q3 | 1 | 1.08 M | $9.56 M |
| 2024 Q2 | 102 | 329 M | $89.2 M |
| 2024 Q1 | 111 | 315 M | $130 M |
| 2023 Q4 | 90 | 57.3 M | $23.5 M |
| 2023 Q3 | 72 | 23.4 M | $24.5 M |
| 2023 Q2 | 63 | 4.09 M | $1.56 M |
| 2023 Q1 | 67 | 7.37 M | $2.84 M |
| 2022 Q4 | 71 | 11.4 M | $3.45 M |
| 2022 Q3 | 63 | 16.9 M | $8.22 M |
| 2022 Q2 | 61 | 14.6 M | $8.19 M |
| 2022 Q1 | 52 | 15.5 M | $12.6 M |
| 2021 Q4 | 67 | 16.4 M | $19.5 M |
| 2021 Q3 | 51 | 23.7 M | $51.9 M |
| 2021 Q2 | 2 | 57.8 k | $117 k |
| 2021 Q1 | 1 | 20.0 k | $20.0 k |
| 2020 Q4 | 1 | 27.3 k | $40.6 M |